Savior Lifetec Corporation is a pharmaceutical company specializing in the research, development, and production of generic drugs. The company focuses on therapeutic areas including cardiovascular, respiratory, and nervous system disorders. It manufactures carbapenem antibiotics, utilizing vertical integration that spans from active pharmaceutical ingredient manufacturing to finished dosage forms. Savior Lifetec provides contract development and manufacturing services, including formulation development, quality control, production, and regulatory affairs support. The company holds GMP certifications and has passed audits by the US FDA and the European Medicines Agency. Its products are registered with health authorities in various markets, and the company serves global customers through its pharmaceutical value chain services.

Summarised from the company's own disclosures, fiscal year ended Oct 2026

Industry Drug Manufacturers - Specialty & Generic Homepage saviorlifetec.com.tw
Sector Healthcare IR page —
Tags
generic drugs, carbapenem antibiotics, cardiovascular, respiratory system, nervous system, contract manufacturing, formulation development, quality control, regulatory affairs, active pharmaceutical ingredients, Savior Lifetec Corporation
Press page —

Metrics

Valuation  
Market cap NT$ 5.589B
Market cap (USD) $ 169.628M
P/E 6.51
PEG 0.04
P/BV 1.30
P/S 4.83
P/OCF 10.78
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 14.7%
ROI 14.2%
ROIC 4.8%
Profit margin 44.7%
Growth  
Revenue growing No
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) 145.4%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock Yes
Diluting (TTM) Yes
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 25.0%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 1.202B 1.217B 1.05B 1.266B 1.744B 1.827B 1.319B 1.105B 1.618B 1.532B 1.121B 1.019B 1.001B
Net profit 537.449M 182.38M 30.03M 36.387M 9.956M 250.941M -4.934M -359.547M 22.273M -207.697M -493.793M -355.79M -228.703M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Share price 18.4 — — — — — — — — — — — —
P/S 4.75 — — — — — — — — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

公告本公司董事會重要決議事項 Bull 0 Bear 0 Routine

Prompts

Savior Lifetec Corporation (ticker 4167.TWO), listed in Taiwan.

ETFs Holding Savior Lifetec Corporation

ETF Weight in ETF Shares Market value As of
AVEE 0.01% 27,768 $ 15.221K Nov 16, 2026
DEXC 0.01% 32,244 $ 18.582K Nov 12, 2026
DFEV 0.00% 122,820 $ 70.78K Nov 12, 2026
DFEM 0.00% 385,548 $ 222.188K Nov 12, 2026
DFAE 0.00% 303,312 $ 174.796K Nov 12, 2026
DFAX 0.00% 220,711 $ 127.194K Nov 12, 2026
AVEM 0.00% 159,132 $ 87.228K Nov 16, 2026
AVSE 0.00% 5,340 $ 2,927.11 Nov 16, 2026
AVXC 0.00% 1,068 $ 585.42 Nov 16, 2026